Guy Douglas Eslick

Guy Douglas Eslick is a Professor at the University of Sydney, associated with the Children's Hospital Westmead Clinical School and the Australian Paediatric Surveillance Unit in Sydney Medical School. He completed his PhD in Medicine at the University of Sydney in 2004, with a thesis titled 'Epidemiology of Non-Cardiac Chest Pain.' Eslick also holds a Doctor of Public Health (DrPH) from the University of Sydney. His career includes a tenure as Professor of Cancer Epidemiology and Medical Statistics in the Department of Surgery at the University of Sydney from April 2010 to September 2020. Prior affiliations encompass the Harvard School of Public Health, where he contributed as a researcher in molecular and genetic epidemiology.

Eslick specializes in population-based epidemiology, meta-analyses, and systematic reviews, focusing on cancer risk factors, causal factors, gastrointestinal disorders, sepsis, vaccine safety, bone health, hyperlipidemia, dysphagia, Alzheimer's disease, and paediatric conditions. With over 200 publications, his highly cited works include 'Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis' (The Lancet Infectious Diseases, 2007; 1320 citations), 'Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies' (Vaccine, 2014; 1048 citations), 'Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis' (The Lancet, 2007), 'Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis' (American Journal of Gastroenterology, 1999; 640 citations), 'Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis' (Critical Care Medicine, 2009; 501 citations), 'Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis' (European Journal of Nutrition, 2016; 484 citations), and 'Non-cardiac chest pain: prevalence, risk factors, impact and consulting—a population-based study' (Alimentary Pharmacology & Therapeutics, 2003; 403 citations). Recent contributions involve analyzing the 2022 global outbreak of severe acute hepatitis in children, underscoring the importance of disease surveillance. His research has shaped clinical practices and public health understandings in epidemiology and paediatrics.

Professional Email: guy.eslick@sydney.edu.au